Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study

Navdeep Tangri, Dana C Miskulin, Jing Zhou, Karen Bandeen-Roche, Wieneke M Michels, Patti L Ephraim, Aidan McDermott, Deidra C Crews, Julia J Scialla, Stephen M Sozio, Tariq Shafi, Bernard G Jaar, Klemens Meyer, L Ebony Boulware, DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators, L Ebony Boulware, Karen Bandeen-Roche, Courtney Cook, Josef Coresh, Deidra Crews, Patti Ephraim, Bernard Jaar, Jeonyong Kim, Yang Liu, Jason Luly, Aidan McDermott, Wieneke Michels, Paul Scheel, Tariq Shafi, Stephen Sozio, Albert Wu, Jing Zhou, Allan Collins, Robert Foley, David Gilbertson, Haifeng Guo, Brooke Heubner, Charles Herzog, Jiannong Liu, Wendy St Peter, Joseph Nally, Susana Arrigain, Stacey Jolly, Vicky Konig, Xiaobo Liu, Sankar Navaneethan, Jesse Schold, Philip Zager, Dana Miskulin, Klemens Meyer, Julia Scialla, Navdeep Tangri, Wieneke Michels

2015-04-01

Abstract:Background Intravenous iron use in hemodialysis patients has greatly increased over the last decade, despite limited studies on the safety of iron. Methods We studied the association of receipt of intravenous iron with hospitalizations in an incident cohort of hemodialysis patients. We examined 9544 patients from Dialysis Clinic, Inc. (DCI). We ascertained intravenous iron use from DCI electronic medical record and USRDS data files, and hospitalizations through Medicare claims. We examined the association between iron exposure accumulated over 1-, 3- or 6-month time windows and incident hospitalizations in the follow-up period using marginal structural models accounting for time-dependent confounders. We performed sensitivity analyses including recurrent events models for multiple hospitalizations and models for combined outcome of hospitalization and death …